198 results on '"Eberlein, Uta"'
Search Results
2. Analysis of image data from the EuroNet PHL-C2 trial indicates a potential reduction in injected F-18 FDG activities in children: a proposal to update the EANM Paediatric Dosage Card
3. Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project
4. SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T
5. Future Perspectives of Artificial Intelligence in Bone Marrow Dosimetry and Individualized Radioligand Therapy
6. European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer
7. An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine
8. GATE/Geant4-based dosimetry for ex vivo in solution irradiation of blood with radionuclides
9. Repair of α-particle-induced DNA damage in peripheral blood mononuclear cells after internal ex vivo irradiation with 223Ra
10. Radiation-induced double-strand breaks by internal ex vivo irradiation of lymphocytes: Validation of a Monte Carlo simulation model using GATE and Geant4-DNA
11. EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
12. The effect of modern PET technology and techniques on the EANM paediatric dosage card
13. DNA Damage and Repair in PBMCs after Internal Ex Vivo Irradiation with [ 223 Ra]RaCl 2 and [ 177 Lu]LuCl 3 Mixtures.
14. EANM position paper on the role of radiobiology in nuclear medicine
15. Human Biodistribution and Radiation Dosimetry of 18F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway
16. Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand
17. European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer
18. Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours.
19. Modelling the In Vivo and Ex Vivo DNA Damage Response after Internal Irradiation of Blood from Patients with Thyroid Cancer.
20. Biodistribution and Radiation Dosimetry for a Probe Targeting Prostate-Specific Membrane Antigen for Imaging and Therapy
21. Analysis of image data from the EuroNet PHL-C2 trial indicates a potential reduction in injected F-18 FDG activities in children: a proposal to update the EANM Paediatric Dosage Card
22. Internal Dosimetry: Principles and Applications to NET
23. DNA damage in blood leucocytes of prostate cancer patients during therapy with 177Lu-PSMA
24. Radiation Safety and Dosimetry
25. Physics of Radioguided Surgery: Basic Principles and Methods of Radiation Detection
26. Radiation Risk from Medical Exposure in Children
27. SUVmean on baseline [18F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [177Lu]Lu-PSMA I&T.
28. Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [223Ra]RaCl2 and [224Ra]RaCl2
29. 90 years after the discovery of the positron – positron emission tomography has become a unique diagnostic and theranostic tool
30. DNA DAMAGE AFTER INTERNAL EX VIVO IRRADIATION OF BLOOD WITH α-PARTICLES AS A FUNCTION OF TIME AND ABSORBED DOSE
31. 177Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model
32. Standardization of administered activities in paediatric nuclear medicine: the EANM perspective
33. Internal Dosimetry: Principles and Applications to NET
34. Correlation of the absorbed dose to the blood and DNA damage in leukocytes after internal ex-vivo irradiation of blood samples with Ra-224
35. GATE/Geant4-based dosimetry for ex vivo in solution irradiation of blood with radionuclides
36. EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
37. DNA damage in blood lymphocytes in patients after 177Lu peptide receptor radionuclide therapy
38. The effect of modern PET technology and techniques on the EANM paediatric dosage card
39. mRNA and small RNA gene expression changes in peripheral blood to detect internal Ra-223 exposure
40. Dosimetry for Radiopharmaceutical Therapy: The European Perspective
41. Repair of α-particle-induced DNA damage in peripheral blood mononuclear cells after internal ex vivo irradiation with 223Ra.
42. Dosimetry for Radiopharmaceutical Therapy:The European Perspective
43. Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine – a review
44. mRNA and small RNA gene expression changes in peripheral blood to detect internal Ra-223 exposure.
45. Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project
46. DNA Damage in Blood Leukocytes of Prostate Cancer Patients Undergoing PET/CT Examinations with [\(^{68}\)Ga]Ga-PSMA I&T
47. DNA Damage in Blood Leukocytes of Prostate Cancer Patients Undergoing PET/CT Examinations with [68Ga]Ga-PSMA I&T
48. 90 - DNA DAMAGE AFTER INTERNAL EX VIVO IRRADIATION OF BLOOD WITH α-PARTICLES AS A FUNCTION OF TIME AND ABSORBED DOSE
49. Induction and repair of DNA double-strand breaks in blood leukocytes of prostate cancer patients during Lu-177-PSMA therapy
50. DNA damage in leukocytes after internal ex-vivo irradiation of blood with the α-emitter Ra-223
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.